Skin microbiota: a source of disease or defence? | British Journal of Dermatology | 2008 | 549 |
Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers | Journal of Investigative Dermatology | 2008 | 179 |
Administration of oral vitamin D induces cathelicidin production in atopic individuals | Journal of Allergy and Clinical Immunology | 2008 | 177 |
IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes | Journal of Immunology | 2008 | 144 |
Management of atopic dermatitis in the pediatric population | Pediatrics | 2008 | 141 |
Practical considerations in acne treatment and the clinical impact of topical combination therapy | Pediatric Dermatology | 2008 | 140 |
Monetary sacrifice among strangers is mediated by endogenous oxytocin release after physical contact | Evolution and Human Behavior | 2008 | 130 |
Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3 | Journal of Investigative Dermatology | 2008 | 124 |
Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes | Journal of Investigative Dermatology | 2008 | 103 |
Antimicrobial peptides in human skin disease | European Journal of Dermatology | 2008 | 95 |
Antimicrobial peptides, skin infections, and atopic dermatitis | Seminars in Cutaneous Medicine and Surgery | 2008 | 80 |
Toll-like receptors in skin infections and inflammatory diseases | Infectious Disorders - Drug Targets | 2008 | 80 |
A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence | FASEB Journal | 2008 | 79 |
Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination | Journal of Controlled Release | 2008 | 70 |
Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases | Journal of the American Academy of Dermatology | 2008 | 64 |
Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris | PLoS ONE | 2008 | 59 |
Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds | Plastic and Reconstructive Surgery | 2008 | 58 |
Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris | Journal of Investigative Dermatology | 2008 | 54 |
Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes | Journal of Investigative Dermatology | 2008 | 46 |
Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis | Journal of Immunology | 2008 | 39 |
Skin and hair: models for exploring organ regeneration | Human Molecular Genetics | 2008 | 31 |
Superficial chemical peels and microdermabrasion for acne vulgaris | Seminars in Cutaneous Medicine and Surgery | 2008 | 28 |
Bioengineering a humanized acne microenvironment model: proteomics analysis of host responses to Propionibacterium acnes infection in vivo | Proteomics | 2008 | 28 |
Sounding the alarm: multiple functions of host defense peptides | Journal of Investigative Dermatology | 2008 | 24 |
Innate barriers against infection and associated disorders | Drug Discovery Today Disease Mechanisms | 2008 | 20 |